Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies ; volume:15 ; number:1 ; day:22 ; month:8 ; year:2018 ; pages:1-12 ; date:12.2018
Retrovirology ; 15, Heft 1 (22.8.2018), 1-12, 12.2018

Creator: Parsons, Matthew S.

Contributor: Chung, Amy W.
Kent, Stephen J.
SpringerLink (Online service)

DOI: 10.1186/s12977-018-0438-x

URN: urn:nbn:de:101:1-2018101620383905772482

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Parsons, Matthew S.
Chung, Amy W.
Kent, Stephen J.
SpringerLink (Online service)

Other Objects (12)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Design clues from functional constraints and broadly neutralizing antibodies

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

Hochschulschrift

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Design clues from functional constraints and broadly neutralizing antibodies

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

Hochschulschrift

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Design clues from functional constraints and broadly neutralizing antibodies

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

Hochschulschrift

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Design clues from functional constraints and broadly neutralizing antibodies

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Design clues from functional constraints and broadly neutralizing antibodies

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

Broadly Neutralizing Antibodies for HIV Eradication

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Design clues from functional constraints and broadly neutralizing antibodies

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

Identification and characterization of broadly neutralizing antibodies targeting viral infections

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Broadly neutralizing antibodies and vaccine design against HIV-1 infection

Related objects

Reset password